(lp0
S'Cytokinetics Announces Additional Results From COSMIC-HF Presented at ACC.17 GlobeNewswire  - 19 hours ago SOUTH SAN FRANCISCO, Calif., March 20, 2017  -- Cytokinetics, Inc.  today announced that additional results from COSMIC-HF , a Phase&nbsp;...'
p1
aS"Cytokinetics, Inc. Reports Fourth Quarter 2016 Financial Results GlobeNewswire  - Feb 16, 2017 16, 2017  -- Cytokinetics, Inc.  reported total revenues for the fourth quarter of 2016 were $33.1 million, compared to $9.8 million, during the same period in 2015.Cantor Fitzgerald Releases a Buy Rating on Cytokinetics Inc - Analyst RatingsCytokinetics'  CEO Robert Blum on Q4 2016 Results - Earnings Call Transcript - Seeking Alpha"
p2
aS"Why Cytokinetics, Inc. Got Hammered Today Motley Fool - Sep 1, 2016 What happened. Cytokinetics  is down 13% heading into the closing bell Thursday after announcing plans to start a phase 3 clinical trial for its heart medication omecamtiv mecarbil.Here's Why You Should Buy Cytokinetics, Inc.  As Amgen, Inc. (AMGN ... - TCCCytokinetics , Amgen  to Advance Omecamtiv Mecarbil to Phase 3 - StreetInsider.com"
p3
aS'Cytokinetics, Inc.  Stake Increased by Fmr LLC Chaffey Breeze - Mar 19, 2017 Cytokinetics logo Fmr LLC boosted its stake in Cytokinetics, Inc.  by 2.7% during the fourth quarter, according to its most recent disclosure with the SEC.'
p4
aS'Cytokinetics Inc. MarketWatch - Dec 21, 2009 Cytokinetics Inc. NASDAQ: CYTK. GO. Set Alerts &middot; Find a Broker &middot; Join TD Ameritrade &middot; Market Index &middot; Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.'
p5
aS"JMP Securities Bullish on Cytokinetics, Inc.  Following 2Q Update; Sees ... Smarter Analyst - Aug 1, 2016 In light of Cytokinetics, Inc.'s  second-quarter update, JMP Securities analyst Jason Butler remains bullish for the biotech company's pipeline drug-paved road ahead."
p6
aS'Cytokinetics Announces Start of GALACTIC-HF, a Phase 3 Clinical Trial of ... GlobeNewswire  - Dec 1, 2016 SOUTH SAN FRANCISCO, Calif., Dec. 01, 2016  -- Cytokinetics, Inc.  today announced the activation of the first clinical site and the start of GALACTIC-HF (Global Approach to Lowering Adverse Cardiac Outcomes&nbsp;...Amgen, Cytokinetics Launch Heart Study  - InvestopediaCytokinetics earns $26.7M milestone from Amgen on start of large-scale CV ... - Seeking Alpha'
p7
aS'Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day GlobeNewswire  - Feb 28, 2017 SOUTH SAN FRANCISCO, Calif., Feb. 28, 2017  -- Cytokinetics, Inc.  today announced that it is joining the global initiative with the European Organisation for Rare Diseases  and the National Organization for&nbsp;...Cytokinetics to Present at March Investor Conferences - Yahoo Finance'
p8
aS'Cowen Positive on Cytokinetics, Inc.  as Amgen, Inc.  Opts-in to ... Smarter Analyst - Oct 5, 2016 Cowen top analyst Ritu Baral chimes in on Cytokinetics, Inc.  after Amgen, Inc.  recently opted-in to advance their collaborative drug omecamtiv mercarbil, designed to treat people living with heart failure.'
p9
aS"Cytokinetics and Astellas Announce Option Right for Tirasemtiv and Expansion ... GlobeNewswire  - Jul 27, 2016 SOUTH SAN FRANCISCO, Calif. and TOKYO, July 27, 2016  -- Cytokinetics, Inc.   and Astellas Pharma Inc.   today announced that Cytokinetics and Astellas have expanded their&nbsp;...With latest swing, Peninsula biotech tries to double up Lou Gehrig's disease - San Francisco Business Times Cytokinetics Gets $95M in First ALS Deal, Needs Results For More - Xconomy"
p10
a.